Susquehanna Issues Pessimistic Forecast for Lumentum (NASDAQ:LITE) Stock Price

Key Points

• Susquehanna lowered Lumentum’s price target to $950 from $1,100 while maintaining a positive rating, implying 38.81% upside; analysts overall give the stock a “Moderate Buy” consensus with a $1,052.17 target.
• Lumentum beat quarterly earnings expectations with adjusted EPS of $4.57 versus $4.22 forecast, while revenue reached $1.26 billion, up 136.5% year over year.
• The proposed all-stock combination with Marvell carries an implied enterprise value of about $115 billion, but investors remain concerned about dilution, valuation, integration risks and shareholder challenges over the deal’s fairness.

Lumentum (NASDAQ:LITE - Get Free Report) had its target price dropped by equities research analysts at Susquehanna from $1,100.00 to $950.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a "positive" rating on the technology company's stock. Susquehanna's price target indicates a potential upside of 38.81% from the stock's current price.

LITE has been the subject of several other research reports. Raymond James Financial upgraded Lumentum from an "outperform" rating to a "strong-buy" rating and set a $1,328.00 target price for the company in a research report on Monday. Zacks Research cut Lumentum from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 12th. UBS Group set a $820.00 price objective on Lumentum in a research note on Wednesday, August 12th. Weiss Ratings cut Lumentum from a "hold (c-)" rating to a "sell (d-)" rating in a report on Wednesday, August 19th. Finally, Rosenblatt Securities reduced their target price on shares of Lumentum from $1,300.00 to $900.00 and set a "buy" rating on the stock in a research note on Tuesday. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Lumentum has an average rating of "Moderate Buy" and a consensus target price of $1,052.17.

Lumentum Stock Performance

NASDAQ LITE opened at $684.40 on Tuesday. Lumentum has a twelve month low of $184.20 and a twelve month high of $1,143.00. The company has a quick ratio of 1.40, a current ratio of 1.68 and a debt-to-equity ratio of 0.01. The stock has a market cap of $61.99 billion, a P/E ratio of -8.33 and a beta of 1.53. The company's 50-day simple moving average is $919.26 and its 200 day simple moving average is $796.61.

Lumentum (NASDAQ:LITE - Get Free Report) last announced its quarterly earnings results on Monday, November 2nd. The technology company reported $4.57 EPS for the quarter, topping analysts' consensus estimates of $4.22 by $0.35. The firm had revenue of $1.26 billion during the quarter, compared to analysts' expectations of $1.26 billion. Lumentum had a negative net margin of 230.15% and a positive return on equity of 26.34%. The company's revenue for the quarter was up 136.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.10 earnings per share. As a group, research analysts forecast that Lumentum will post 19.79 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Lumentum news, CFO Wajid Ali sold 24,542 shares of Lumentum stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $1,048.50, for a total value of $25,732,287.00. Following the completion of the transaction, the chief financial officer owned 75,074 shares in the company, valued at approximately $78,715,089. The trade was a 24.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Yuen Wupen sold 307 shares of the business's stock in a transaction on Tuesday, September 29th. The stock was sold at an average price of $945.00, for a total value of $290,115.00. Following the completion of the transaction, the insider directly owned 108,320 shares in the company, valued at approximately $102,362,400. This represents a 0.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 94,496 shares of company stock valued at $85,978,498 over the last ninety days. Insiders own 0.28% of the company's stock.

Institutional Investors Weigh In On Lumentum

A number of hedge funds have recently added to or reduced their stakes in LITE. Alps Advisors Inc. boosted its holdings in shares of Lumentum by 13.7% in the 3rd quarter. Alps Advisors Inc. now owns 540 shares of the technology company's stock valued at $524,000 after purchasing an additional 65 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in shares of Lumentum during the 3rd quarter worth $236,000. Ariose Capital Management Ltd acquired a new stake in Lumentum in the third quarter valued at about $9,523,000. Alta Advisers Ltd boosted its stake in Lumentum by 110.4% in the third quarter. Alta Advisers Ltd now owns 646 shares of the technology company's stock valued at $627,000 after buying an additional 339 shares in the last quarter. Finally, Glaxis Capital Management LLC bought a new position in Lumentum in the third quarter valued at about $1,263,000. Institutional investors own 94.05% of the company's stock.

Trending Headlines about Lumentum

Here are the key news stories impacting Lumentum this week:

• Positive Sentiment: Lumentum beat fiscal first-quarter expectations, reporting $4.57 in adjusted EPS versus the $4.22 consensus estimate. Revenue was approximately $1.26 billion, up 136.5% year over year and in line with forecasts. Lumentum Beats Q1 Earnings and Revenue Estimates
• Positive Sentiment: The proposed combination would unite Marvell’s custom silicon and networking technology with Lumentum’s optical components, creating a larger AI-data-center connectivity platform and potentially giving the combined company greater scale in a rapidly expanding market. Marvell and Lumentum to Combine
• Neutral Sentiment: The transaction would be financed entirely with stock. Lumentum shareholders would receive 4.5 Marvell shares per Lumentum share and own about 33% of the combined company; the deal carries an implied enterprise value of roughly $115 billion, including debt. Its final value will fluctuate with Marvell’s share price. Marvell Buys Lumentum for $115 Billion
• Negative Sentiment: Investors appear concerned that Marvell is paying an aggressive price at a time when the AI infrastructure boom is facing questions about spending durability and returns. Analysts have cited dilution, limited near-term upside and integration risk, while comparisons with past technology bubbles have further pressured the shares. Stocks Downgraded on Merger Concerns
• Negative Sentiment: Shareholder-rights law firms are investigating whether Lumentum is receiving a fair price and whether insiders’ interests or deal restrictions could limit competing offers. These reviews add uncertainty around approval and completion. Lumentum Shareholder Investigation

About Lumentum

Lumentum Holdings Inc is a technology company that designs and manufactures optical and photonic products for communications networks, industrial applications, and consumer electronics. Its portfolio includes optical components, modules, and subsystems used in fiber-optic networks, data centers, cloud computing infrastructure, telecommunications equipment, and high-speed connectivity systems.

The company also develops laser products for applications such as industrial processing, sensing, three-dimensional imaging, and other specialized commercial and consumer uses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.